AlloVir, Inc. (ALVR)
NASDAQ: ALVR · IEX Real-Time Price · USD
0.745
-0.015 (-2.01%)
At close: Jul 19, 2024, 4:00 PM
0.740
-0.005 (-0.63%)
Pre-market: Jul 22, 2024, 5:58 AM EDT
AlloVir Market Cap
AlloVir has a market cap or net worth of $85.64 million as of July 22, 2024. Its market cap has decreased by -70.19% in one year.
Market Cap
85.64M
Enterprise Value
-37.10M
1-Year Change
-70.19%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since July 30, 2020, AlloVir's market cap has decreased from $1.55B to $85.64M, a decrease of -94.49%. That is a compound annual growth rate of -51.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 85.70M | 10.44% |
| Dec 29, 2023 | 77.60M | -83.76% |
| Dec 30, 2022 | 477.90M | -43.30% |
| Dec 31, 2021 | 842.90M | -66.32% |
| Dec 31, 2020 | 2.50B | 61.14% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HilleVax | 88.01M |
| Tiziana Life Sciences | 87.62M |
| Clearside Biomedical | 87.44M |
| Hyperfine | 86.77M |
| Benitec Biopharma | 86.37M |
| CASI Pharmaceuticals | 85.10M |
| Verastem | 84.08M |
| AN2 Therapeutics | 83.22M |